Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Documentation

  • Home >
  • Investors & media >
  • Documentation
23 June 2017
Regulated information

Securities Note visa 17-397 Open in new window

10 May 2017
General meetings

2016 Registration Document Open in new window

10 May 2017
General meetings

Supplementary report of the Board on the issuance of ordinary shares on July 12, 2016 Open in new window

10 May 2017
General meetings

Table of summary results for the past 5 years Open in new window

10 May 2017
General meetings

Supplementary report of the Board on the issuance of share warrants on July 26, 2016 Open in new window

10 May 2017
General meetings

Auditors’ report on the issuance of share warrants Open in new window

10 May 2017
General meetings

Auditors’ report on the issuance of ordinary shares by public offering Open in new window

10 May 2017
General meetings

Auditors’ report on the conversion of preference shares Open in new window

10 May 2017
General meetings

Report of auditors on 2016 financial statements in accordance with French GAAP Open in new window

10 May 2017
General meetings

Auditors’ report on the issuance of ordinary shares by public offering Open in new window

  • View previous 9 articles
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • View next 9 articles
© 2025 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page